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Abstract 
Schilder’s disease is a rare sporadic demyelinating disease of the brain. We report a girl with Schilder’s 
disease who had undergone Kasai operation for biliary atresia. The patient presented with acute right 
hemiparesis. Brain magnetic resonance imaging (MRI) showed a single large tumefactive white 
matter lesion. A diagnosis of Schilder’s disease was based on clinical features and MRI findings. The 
patient showed dramatic clinical improvement and significant regression of the lesion in response to 
high-dose intravenous methyl prednisone, and remained free of relapse of other neurologic problems 
during the 3-year follow-up.
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INTRODUCTION
Schilder’s disease, also known as myelinoclastic 
diffuse sclerosis, was first described by Schilder 
in 1912.1 It is a sporadic subacute demyelinating 
brain disease that usually affects children. This 
rare disease results in formation of one or two 
bilateral large tumefactive plaques.2 The clinical 
presentation is atypical for pediatric multiple 
sclerosis, and radiologic findings often mimic 
brain tumor or abscess. Clinical course or 
treatments for Schilder’s disease have not been 
clearly established. However, some radiological 
characteristics and clinical features suggest 
differential diagnosis from other demyelinating 
diseases, brain tumors, or abscess. Here we 
contribute to the understanding of Schilder’s 
disease by presenting the case of a child with 
Schilder’s disease who underwent a Kasai 
operation for biliary atresia.
CASE REPORT
A girl 6 years and 9 months of age who had 
previously undergone a Kasai operation at one 
month of age due to biliary atresia presented with 
acute right side hemiparesis. A year prior to the 
incident, she presented with tingling sensation 
both toes and clumsy gait for about 3 days. The 
symptoms disappeared spontaneously. Brain 
magnetic resonance imaging (MRI) showed 
a tumefactive demyelinating lesion with ill-
defined peripheral enhancement in the left fronto-
parietal white matter (Figure 1). A demyelinating 
disease such as multiple sclerosis was suspected, 
but brain MRI was not typical for multiple 
sclerosis. Therefore, we diagnosed this patient 
with Schilder’s disease while performing further 
evaluation. Oligoclonal bands in cerebrospinal 
fluid (CSF) were negative, and a spine MRI 
showed no abnormalities. The liver disease 
indicators including aspartate aminotransferase 
(AST), alanin aminotransferase (ALT), and gamma 
glutamyl transferase (GGT) were increased to 60 
IU/L, 269 IU/L, and 234 IU/L, respectively, and 
liver cirrhosis was detected. Her vitamin E level, 
which was obtained during convalescence was 9.4 
mg/L (3.8-18.4 mg/L) and her cholesterol level 
was 187 mg/dL (100-240 mg/dL).
 The patient was treated with methyl 
prednisolone (10 mg/kg/day) intravenously for 
10 days. Hemiparesis disappeared about fifth 
day of treatment, allowing the patient to walk 
independently, and the size of the brain lesion 
decreased on MRI (Figure 2). However, she 
showed intention tremor in her right arm and 
dystonia in her right foot although hemiparesis 
has resolved, which were noted during the methyl 
prednisolone treatment. After methyl prednisolone 
therapy, oral prednisone (1 mg/kg/day) was given. 
The oral prednisone was gradually tapered over 
6 months. The patient fully recovered from 
intention tremor and dystonia 2 months after 
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oral prednisone treatment, with no relapse of 
neurological symptom during the 3-year follow-
up.
DISCUSSION 
The diagnostic criteria of Schilder’s disease 
proposed by Poser are as follows.2 It is a 
subacute myelinoclastic disorder resulting in 
formation of one, or more commonly, two roughly 
symmetric bilateral plaques measuring at least 
2×3 cm in two of three dimensions, involving 
the centrum semiovale. These must be the only 
lesions demonstrable by clinical, paraclinical, 
or imaging studies. There must be no peripheral 
nervous system lesion. Adrenal function and 
very long-chain fatty acids must be normal. The 
histopathology must be identical to multiple 
sclerosis. Our patient fulfills the Poser’s criteria, 
except the absence of histopathology, as brain 
biopsy was not performed. The tests of adrenal 
function were not available, but the patient did 
not show symptoms of adrenal crisis or adrenal 
insifficiency. As suggested in recent studies3, 
improved MRI findings of biopsy-proven cases 
of Schilder’s disease have enabled noninvasive 
diagnosis of Schilder’s disease. In our patient, a 
good response to steroid pulse therapy was also 
supportive of the diagnosis. 
 MRI in Schilder’s disease show a hypointense 
lesion on T1 weighted images and a hyperintense 
lesion on T2 weighted images.3 Open ring contrast 
enhancement caused by an acute inflammatory 
process in the white matter is characteristic.4 Other 
findings are the increased signal on fluid attenuated 
inversion recovery (FLAIR) and an increase in 
the apparent diffusion coefficient (ADC). These 
radiologic features are also supportive of the 
diagnosis of Schilder’s disease.
 In our patient, a possible diagnosis of multiple 
sclerosis was considered based on the 2010 
revisions to the McDonald criteria of MS. She 
had two episodes of clinical attacks and one brain 
MRI lesion for dissemination in space.5 However, 
the single large tumefactive lesion was atypical for 
Figure 1. Initial brain MRI shows demyelinating lesion at left fronto-parietal white matter. A) T1-weighted image; 
B) T2-weighted image; C) T2 FLAIR image.
Figure 2. Brain MRI after 3 months shows resolution of lesions seen in Figure 1, with scarring and a small focal 
area of cavitation. A) T1-weighted image (hypointense); B) T2-weighted image (hyperintense); C) T2 
Flair image (hyperintense).
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multiple sclerosis, but consistent with Schilder’s 
disease. 
 In rare cases of acute disseminated 
encephalomyelitis (ADEM), brain MRI shows a 
large single lesion, predominantly white matter. 
However, we believe that the clinical presentation 
of ADEM must include encephalopathy, which is 
defined as one or more of the following, behavioral 
change and alteration in consciousness.6,7 Our 
patient had two historical evidences of ataxia and 
hemiparesis without any encephalopathy.
 As for the relationship between biliary atresia 
and Schilder’s disease, biliary atresia causes 
cholestasis, or difficulty in secretion of bile acid. 
Therefore, impaired absorption of fat-soluble 
vitamins is common in patients with biliary atresia. 
Vitamin E deficiency is known to be associated 
with various neurologic abnormalities such as 
ataxia, weakness, areflexia, impaired vision, loss 
of proprioception, and vibratory sensation and 
variable ophthalmoplegia.8,9 In our patient, we 
unfortunately could not determine the vitamin E 
level at the moment of hemiparesis. The serum 
vitamin E level determined several months after 
the event was normal and the serum vitamin E 
to total cholesterol ratio was also normal. 
 In conclusion, Schilder’s disease should be 
considered in children with acute or subacute 
neurological symptom, and large tumefactive 
lesion in MRI. 
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